Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Estimating the impact of test-trace-isolate-quarantine systems on SARS-CoV-2 transmission in Australia

Freya M. Shearer, James M. McCaw, Gerard Ryan, Tianxiao Hao, Nicholas J Tierney, View ORCID ProfileMichael Lydeamore, Kate Ward, Sally Ellis, James Wood, View ORCID ProfileJodie McVernon, Nick Golding
doi: https://doi.org/10.1101/2023.01.10.23284209
Freya M. Shearer
1Infectious Disease Dynamics Unit, Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: freya.shearer@unimelb.edu.au
James M. McCaw
1Infectious Disease Dynamics Unit, Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia
2School of Mathematics and Statistics, The University of Melbourne, Melbourne, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gerard Ryan
1Infectious Disease Dynamics Unit, Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia
3Telethon Kids Institute, Perth, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tianxiao Hao
1Infectious Disease Dynamics Unit, Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia
3Telethon Kids Institute, Perth, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nicholas J Tierney
1Infectious Disease Dynamics Unit, Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia
3Telethon Kids Institute, Perth, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael Lydeamore
4Department of Econometrics and Business Statistics, Monash University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Michael Lydeamore
Kate Ward
5Public Health Response Branch, NSW Ministry of Health
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sally Ellis
5Public Health Response Branch, NSW Ministry of Health
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
James Wood
6School of Population Health, The University of New South Wales, Sydney, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jodie McVernon
7Department of Infectious Diseases at the Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Australia
8Victorian Infectious Diseases Reference Laboratory Epidemiology Unit at the Peter Doherty Institute for Infection and Immunity, The University of Melbourne, Melbourne, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Jodie McVernon
Nick Golding
1Infectious Disease Dynamics Unit, Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia
3Telethon Kids Institute, Perth, Australia
9Curtin University, Perth, Australia
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

ABSTRACT

We report on an analysis of Australian COVID-19 case data to estimate the impact of TTIQ systems on SARS-CoV-2 transmission in 2020–21. We estimate that in a low prevalence period in the state of New South Wales (tens of cases per day), TTIQ contributed to a 54% reduction in transmission. In a higher prevalence period in the state of Victoria (hundreds of cases per day), TTIQ contributed to a 42% reduction in transmission. Our results also suggest that case-initiated contact tracing can support timely quarantine in times of system stress. Contact tracing systems for COVID-19 in Australia were highly effective and adaptable in supporting the national suppression strategy through 2020 and 2021.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This work was directly funded by the Australian Government Department of Health Office of Health Protection. Additional support was provided by the National Health and Medical Research Council of Australia through its Centres of Research Excellence (SPECTRUM, GNT1170960) and Investigator Grant Schemes (JMcV Principal Research Fellowship, GNT1117140; FMS Emerging Leader Fellowship, 2021/GNT2010051).

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The study was undertaken as urgent public health action to support COVID-19 pandemic response in Australia. The study used data from the Australian National Notifiable Disease Surveillance System (NNDSS) provided to the Australian Government Department of Health under the National Health Security Agreement for the purposes of national communicable disease surveillance. Data from the NNDSS were supplied after de-identification to the investigator team for the purposes of provision of epidemiological advice to government. Contractual obligations established strict data protection protocols agreed between the University of Melbourne and sub-contractors and the Australian Government Department of Health with oversight and approval for use in supporting pandemic response in Australia and for publication provided by the data custodians represented by the Communicable Diseases Network of Australia. The ethics of the use of these data for these purposes including publication was agreed by the Department of Health with the Communicable Diseases Network of Australia. The study also used routinely collected patient administration data from the New South Wales (NSW) Notifiable Conditions Information Management System (NCIMS). Data was supplied by the NSW Ministry of Health with all records de-identified and securely managed to ensure patient privacy and to ensure study compliance with the National Health and Medical Research Council Ethical Considerations in Quality Assurance and Evaluation Activities. The NSW Public Health Act (2010) allows for such release of data to identify and monitor risk factors for diseases and conditions that have a substantial adverse impact on the population and to improve service delivery. Following review the NSW Ministry of Health determined that this study met that threshold and therefore provided approval for the study to proceed. The project oversight and approval for publication was provided by the NSW Ministry of Health.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

The analyses performed in this study required access to data from the Australian National Notifiable Disease Surveillance System (NNDSS) and the New South Wales (NSW) Notifiable Conditions Information Management System (NCIMS), which are not able to be shared under the terms of our data access agreements. For access to NNDSS data, a request must be submitted via NNDSS.datarequests{at}health.gov.au. For access to NCIMS data, contact the NSW Ministry of Health via https://data.nsw.gov.au/contact.

https://github.com/njtierney/ttiq-simulation

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted January 11, 2023.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Estimating the impact of test-trace-isolate-quarantine systems on SARS-CoV-2 transmission in Australia
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Estimating the impact of test-trace-isolate-quarantine systems on SARS-CoV-2 transmission in Australia
Freya M. Shearer, James M. McCaw, Gerard Ryan, Tianxiao Hao, Nicholas J Tierney, Michael Lydeamore, Kate Ward, Sally Ellis, James Wood, Jodie McVernon, Nick Golding
medRxiv 2023.01.10.23284209; doi: https://doi.org/10.1101/2023.01.10.23284209
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Estimating the impact of test-trace-isolate-quarantine systems on SARS-CoV-2 transmission in Australia
Freya M. Shearer, James M. McCaw, Gerard Ryan, Tianxiao Hao, Nicholas J Tierney, Michael Lydeamore, Kate Ward, Sally Ellis, James Wood, Jodie McVernon, Nick Golding
medRxiv 2023.01.10.23284209; doi: https://doi.org/10.1101/2023.01.10.23284209

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (230)
  • Allergy and Immunology (507)
  • Anesthesia (111)
  • Cardiovascular Medicine (1264)
  • Dentistry and Oral Medicine (207)
  • Dermatology (148)
  • Emergency Medicine (283)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (538)
  • Epidemiology (10056)
  • Forensic Medicine (5)
  • Gastroenterology (502)
  • Genetic and Genomic Medicine (2486)
  • Geriatric Medicine (240)
  • Health Economics (482)
  • Health Informatics (1653)
  • Health Policy (757)
  • Health Systems and Quality Improvement (638)
  • Hematology (250)
  • HIV/AIDS (538)
  • Infectious Diseases (except HIV/AIDS) (11896)
  • Intensive Care and Critical Care Medicine (627)
  • Medical Education (255)
  • Medical Ethics (75)
  • Nephrology (269)
  • Neurology (2304)
  • Nursing (140)
  • Nutrition (354)
  • Obstetrics and Gynecology (458)
  • Occupational and Environmental Health (537)
  • Oncology (1259)
  • Ophthalmology (377)
  • Orthopedics (134)
  • Otolaryngology (226)
  • Pain Medicine (158)
  • Palliative Medicine (50)
  • Pathology (326)
  • Pediatrics (737)
  • Pharmacology and Therapeutics (315)
  • Primary Care Research (282)
  • Psychiatry and Clinical Psychology (2295)
  • Public and Global Health (4850)
  • Radiology and Imaging (846)
  • Rehabilitation Medicine and Physical Therapy (493)
  • Respiratory Medicine (657)
  • Rheumatology (289)
  • Sexual and Reproductive Health (241)
  • Sports Medicine (228)
  • Surgery (273)
  • Toxicology (44)
  • Transplantation (131)
  • Urology (100)